TACROLIMUS for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 374 adverse event reports in the FDA FAERS database where TACROLIMUS was used for Psoriasis.
Most Reported Side Effects for TACROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 8,718 | 9.6% | 1,378 | 3,230 |
| Drug ineffective | 6,214 | 6.8% | 1,108 | 2,069 |
| Product use in unapproved indication | 5,057 | 5.6% | 744 | 1,272 |
| Acute kidney injury | 4,005 | 4.4% | 669 | 2,772 |
| Transplant rejection | 3,526 | 3.9% | 352 | 1,135 |
| Cytomegalovirus infection | 3,320 | 3.7% | 707 | 1,385 |
| Covid-19 | 3,201 | 3.5% | 639 | 2,220 |
| Drug interaction | 2,896 | 3.2% | 184 | 1,495 |
| Diarrhoea | 2,854 | 3.1% | 306 | 1,651 |
| Toxicity to various agents | 2,845 | 3.1% | 239 | 1,400 |
| Death | 2,762 | 3.0% | 2,710 | 293 |
| Pneumonia | 2,655 | 2.9% | 965 | 1,636 |
| Pyrexia | 2,538 | 2.8% | 491 | 1,795 |
| Post transplant lymphoproliferative disorder | 2,529 | 2.8% | 709 | 912 |
| Renal impairment | 2,124 | 2.3% | 338 | 1,173 |
Other Indications for TACROLIMUS
Immunosuppressant drug therapy (24,524)
Renal transplant (14,171)
Immunosuppression (9,959)
Product used for unknown indication (9,566)
Prophylaxis against transplant rejection (7,852)
Prophylaxis against graft versus host disease (5,234)
Liver transplant (4,614)
Heart transplant (2,040)
Lung transplant (1,859)
Graft versus host disease (1,174)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)